Xcyte Therapies Inc

Registration country: 
United States
ISIC Code: 
Xcyte Therapies, Inc., a development stage biotechnology company, develops therapeutic products that enhance the body’s natural immune responses to treat cancer, infectious diseases, and other medical conditions associated with weakened immune systems. Its therapeutic products consist of activated, patient-specific T cells, using the company’s patented and proprietary Xcellerate Technology.